Pharming Group (PHARM.AS) Stock Price
€0.745 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
4 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Pharming Group, AI stock picks, stock alerts and much more.
PHARM.AS AI Stock Analysis
AI stock analysis for PHARM.AS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Pharming Group (PHARM.AS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Pharming Group (PHARM.AS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Pharming Group (PHARM.AS), currently trading at €0.745, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About PHARM.AS
-
Pharming Group N.
-
Symbol
PHARM.AS
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
506.8M
Similar Stocks
 |
Valneva SE VLA.PA |
€3.15 0.3% |
5 |
 |
Financière de Tubize SA TUB.BR |
€118.4 1.7% |
6 |
 |
OSE Immunotherapeutics SA OSE.PA |
€5.72 1.6% |
6 |
 |
UCB SA UCB.BR |
€149.7 2.6% |
5 |
 |
Innate Pharma S.A. IPH.PA |
€1.76 0.1% |
4 |
News
PHARM.AS Alternative Data
Web Traffic
Pharming Group receives an estimated 17621 monthly visitors to pharming.com.
-
Web Traffic
17621
-
Change from Previous Month
29.2%
-
3 Month Change
21.9%
-
YoY Change
21.9%
Youtube Subscribers
Pharming Group has 31 subscribers on its main Youtube channel.
-
Youtube Subscribers
31
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Pharming Group has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
Twitter Followers
Pharming Group has 335 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.6% over the last month.
-
Twitter Followers
335
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
0%
Job Postings
Pharming Group has an estimated 12 open job postings, which is down -29.4% over the last month.
-
Job Postings
12
-
Daily Change
0%
-
1 Month Change
29.4%
-
3 Month Change
40%
News Mentions
Pharming Group was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Pharming Group has 869 employees.
-
LinkedIn Employees
869
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.2%
Business Outlook
According to employee reviews, the business outlook among employees at Pharming Group is 56 out of 100 (neutral).
-
Business Outlook
56
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
PHARM.AS Financials
PHARM.AS Key Metrics
-
Total Revenue
€74.8M
-
Net Income
-€1M
-
Earnings per Share
-€0.0015
-
Free cash flow
€9.4M
-
EBITDA
€7.3M
-
EBITDA Ratio
0.0969285
-
Total Assets
€425.5M
PHARM.AS 2-year Revenue & Income
PHARM.AS 2-year Free Cash Flow
PHARM.AS Technicals
PHARM.AS SMA
PHARM.AS RSI
FAQ
What's the current price of Pharming Group (PHARM.AS) Stock?
The price of an Pharming Group (PHARM.AS) share is €0.745.
What's the market cap of Pharming Group?
The current market cap of Pharming Group is 506.8M.
Should I buy or sell PHARM.AS?
Pharming Group shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Pharming Group is better viewed as a hold or accumulate position while waiting for further developments.
Is Pharming Group a good investment?
The current analysis of Pharming Group's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Pharming Group's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Pharming Group (PHARM.AS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Pharming Group stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Pharming Group (PHARM.AS) that investors often compare it to?
Pharming Group (PHARM.AS) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..
What is the forecast for Pharming Group's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Pharming Group's stock price to be around €0.75 in 2026. Starting from the current price of €0.745, this represents a 0.7% change in price, indicating a neutral outlook for the stock.
How to buy Pharming Group (PHARM.AS) Stock?
Pharming Group stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Pharming Group shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.